Search

everythinglearnresearchcommunity

for

Search:↓

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

Cold Atmospheric Microwave Plasma (CAMP) helps hair cells grow and could potentially treat hair loss.

Proper care and management are crucial for successful hair transplants and minimizing complications.

A pancreatic tumor caused high glucagon levels and symptoms, but treatment reduced glucagon and shrank liver tumors.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Improved nutrition quickly healed the patient's skin lesions.

A young woman with skin issues and weight loss improved after treating her pancreatitis and using skin treatments.

A newborn with severe low blood sugar due to a genetic issue needed major surgery after standard treatments failed.

A cat with a rare pancreatic tumor and diabetes died despite treatment, showing similar symptoms to a human condition.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

More research is needed to understand if GLP-1 agonists affect hair health.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Semaglutide is an effective weekly treatment for obesity, promoting weight loss and improving health, despite some side effects.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.